Principles of Good Practice for Budget Impact Analysis
2014
This report provides recommendations for conducting a Budget Impact Analysis from the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force. National regulatory agencies such as the National Institute for Health and Clinical Excellence in England and Wales and the Pharmaceutical Benefits Advisory Committee in Australia, as well as managed care organizations in the United States, now require that companies submit estimates of both the cost-effectiveness and the likely impact of the new health-care interventions on national, regional, or local health plan budgets. Although standard methods for performing and presenting the results of CEAs are well accepted, the same progress has not been made for BIAs. The Task Force recommends that the budget impact of a new health technology should consider the perspective of the specific health-care decision-maker and that analyses be generated as a series of scenario analyses in the same manner that sensitivity analyses would be provided for CEAs. The primary data sources for estimating the budget impact should be published clinical trial estimates and comparator studies for efficacy and safety of current and new technologies as well as, where possible, the decision-maker's own population for the other parameter estimates. Finally, the Task Force recommends that the analyst use the simplest design that will generate credible and transparent estimates.
Principles of Good Practice for Budget Impact Analysis
Source:
Sullivan SD, Mauskopf JA, Augustovski F et al. Budget Impact Analysis - Principles of Good Practice: Report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force. Value in Health 2014; 17: 5-14. https://doi.org/10.1016/j.jval.2013.08.2291